MARKET

RGEN

RGEN

Repligen
NASDAQ
136.44
+3.81
+2.87%
After Hours: 136.03 -0.41 -0.30% 18:43 02/13 EST
OPEN
133.97
PREV CLOSE
132.63
HIGH
140.75
LOW
133.39
VOLUME
767.02K
TURNOVER
--
52 WEEK HIGH
175.77
52 WEEK LOW
102.97
MARKET CAP
7.68B
P/E (TTM)
5288.37
1D
5D
1M
3M
1Y
5Y
1D
Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells
Seeking Alpha · 10h ago
Repligen Corporation to Announce Fourth Quarter and Full Year Financial Results
Reuters · 5d ago
Repligen Corporation kündigt Veröffentlichung von Finanzergebnissen an
Reuters · 5d ago
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results
Barchart · 6d ago
Weekly Report: what happened at RGEN last week (0202-0206)?
Weekly Report · 6d ago
How Investors May Respond To Repligen (RGEN) Winning Backing For Its AI-Driven Bioprocessing Platform
Simply Wall St · 02/08 00:16
Reassessing Repligen (RGEN) Valuation After Recent Share Price Weakness
Simply Wall St · 02/06 10:04
Weekly Report: what happened at RGEN last week (0126-0130)?
Weekly Report · 02/02 10:11
More
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.